Page last updated: 2024-11-06

tryptophanamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

tryptophanamide: used as inhibitor of chymotrypsin; RN given refers to cpd with unspecified isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

L-tryptophanamide : An amino acid amide that is the carboxamide of L-tryptophan. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID439356
CHEMBL ID227123
CHEBI ID16533
SCHEMBL ID358778
MeSH IDM0072139

Synonyms (33)

Synonym
(s)-alpha-amino-1h-indole-3-propionamide
CHEBI:16533 ,
(2s)-2-amino-3-(1h-indol-3-yl)propanamide
l-tryptophan amide
LTN ,
20696-57-5
l-tryptophanamide
C00977
tryptophanamide
DB04537
CHEMBL227123 ,
trp-nh2
s-tryptophanamide
tryptophanamide, l-
1h-indole-3-propanamide, alpha-amino-, (s)-
einecs 243-977-0
0k2b9sb26h ,
unii-0k2b9sb26h
AKOS010390584
1h-indole-3-propanamide, .alpha.-amino-, (.alpha.s)-
1h-indole-3-propanamide, .alpha.-amino-, (s)-
trytophan amide
tryptophan amide
h-trp-nh2
SCHEMBL358778
(s)-2-amino-3-(1h-indol-3-yl)propanamide
(2s)-2-azanyl-3-(1h-indol-3-yl)propanamide
(2s)-2-amino-3-(1h-indol-3-yl)propionamide
tryptophan imine
Q27095301
bdbm50518653
A879492
DTXSID801316507
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
human metaboliteAny mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (2)

ClassDescription
amino acid amideAn amide of an amino acid formed formally by conversion of the carboxy group to a carboxamido group.
tryptophan derivativeAn amino acid derivative resulting from reaction of tryptophan at the amino group or the carboxy group, or from the replacement of any hydrogen of tryptophan by a heteroatom. The definition normally excludes peptides containing tryptophan residues.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Reverse transcriptase/RNaseH Human immunodeficiency virus 1IC50 (µMol)12,800.00000.00011.076810.0000AID1575185; AID1575187
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID288192Partition coefficient, log P of the compound2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID288184Permeability coefficient through artificial membrane in presence of unstirred water layer by PAMPA2007Bioorganic & medicinal chemistry, Jun-01, Volume: 15, Issue:11
QSAR study on permeability of hydrophobic compounds with artificial membranes.
AID1575185Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins by scintillation counting method2019Bioorganic & medicinal chemistry letters, 02-01, Volume: 29, Issue:3
Multiple weak intercalation as a strategy for the inhibition of polymerases.
AID1575187Inhibition of HIV1 reverse transcriptase assessed as reduction in [3H]dTTP incorporation using poly(rA)/oligo(dT) as template/primer after 30 mins in presence of Triton-X-100 by scintillation counting method2019Bioorganic & medicinal chemistry letters, 02-01, Volume: 29, Issue:3
Multiple weak intercalation as a strategy for the inhibition of polymerases.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (9)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (33.33)18.7374
1990's1 (11.11)18.2507
2000's3 (33.33)29.6817
2010's2 (22.22)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other9 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]